Multiple α1-adrenergic receptor subtypes support synergistic stimulation of vasopressin and oxytocin release by ATP and phenylephrine

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 299, Issue 6, 2010, Pages

  Song, Zhilin ^a   Gomes, Dayane A ^a   Stevens, Wanida ^a   Sladek, Celia D ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Hypothalamus; Neurohypophysis; Supraoptic nucleus

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; OXYTOCIN; PHENYLEPHRINE; VASOPRESSIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; VASOPRESSIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG POTENTIATION; GENE ACTIVATION; HORMONE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUPRAOPTIC NUCLEUS; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECT; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; NERVE CELL; NEUROHYPOPHYSIS; SECRETION; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ANALYSIS OF VARIANCE; ANIMALS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NEURONS; OXYTOCIN; PHENYLEPHRINE; PITUITARY GLAND, POSTERIOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; SUPRAOPTIC NUCLEUS; VASOPRESSINS;

EID: 78649836277     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00532.2010     Document Type: Article

References (44)

1. Acosta-Martinez M, Fiber JM, Brown RD, Etgen AM. Localization of alpha1B-adrenergic receptor in female rat brain regions involved in stress and neuroendocrine function. Neurochem Intl 35: 383-391, 1999.
2. v4.2 potassium channels in postsynaptic membrane of rat supraoptic neurons: an ultrastructural study. Neuroscience 77: 617-621, 1997.
3. Armstrong WE, Gallagher MJ, Sladek CD. Noradrenergic stimulation of supraoptic neuronal activity and vasopressin release in vitro: Mediation by a alpha-1-receptor. Brain Res 365: 192-197, 1986.
4. Buller KM, Khanna S, Sibbald JR, Day TA. Central noradrenergic neurons signal via ATP to elicit vasopressin response to haemorrhage. Neuroscience 73: 637-642, 1996.
5. Chalothorn D, McCune DF, Edelmann SE, Garcia-Cazarin ML, Tsujimoto G, Piascik MT. Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes. Mol Pharmacol 61: 1008-1016, 2002.
6. Civantos Calzada B, Aleixandre de Artinano A. Alpha-adrenoceptor subtypes. Pharmacol Res 44: 195-208, 2001.
7. Day TA, Randle JCR, Renaud LP. Opposing alpha- and beta-adrenergic mechanisms mediate dose-dependent actions of noradrenaline on supraoptic vasopressin neurones in vivo. Brain Res 358: 171-179, 1985.
8. Day TA, Renaud LP. Electrophysical evidence that noradrenergic afferents selectively facilitate the activity of supraoptic vasopressin neurons. Brain Res 303: 233-240, 1984.
9. Day TA, Renaud LP, Sibbald JR. Excitation of supraoptic vasopressin cells by stimulation of the A1 noradrenaline cell group: Failure to demonstrate role for established adrenergic or amino acid receptors. Brain Res 516: 91-98, 1990.
10. Day TA, Sibbald JR, Khanna S. ATP mediates an excitatory noradrenergic neuron input to supraoptic vasopressin cells. Brain Res 607: 341-344, 1993. (Pubitemid 23104987)
11. Earnest DJ, Sladek CD. Circadian vasopressin release from perifused rat suprachiasmatic explants in vitro: Effects of acute stimulation. Brain Res 422: 398-402, 1987.
12. + current in rat hippocampal pyramidal neurons. J Neurosci 26: 9340-9348, 2006.
13. Giardina D, Crucianelli M, Romanelli R, Leonardi A, Poggesi E, Melchiorre C. Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7- dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin-1-yl]- furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1Badrenoceptor antagonist. J Med Chem 39: 4602-4607, 1996. (Pubitemid 26382845)
14. Gomes DA, Song Z, Stevens W, Sladek CD. Sustained stimulation of vasopressin and oxytocin release by ATP and phenylephrine requires recruitment of desensitization resistant P2X purinergic receptors. Am J Physiol Regul Integr Comp Physiol 297: R940-R949, 2009.
15. Gonzalez-Cabrera PJ, Gaivin RJ, Yun J, Ross SA, Papay RS, Mc- Cune DF, Rorabaugh BR, Perez DM. Genetic profiling of alpha 1-ad- renergic receptor subtypes by oligonucleotide microarrays: coupling to interleukin-6 secretion but differences in STAT3 phosphorylation and gp-130. Mol Pharmacol 63: 1104-1116, 2003.
16. Gordon GRJ, Baimoukhametova DV, Hewitt SA, Kosala WRA, Rajapaksha JS, Fisher TE, Bains JS. Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. Nat Neurosci 8: 1078-1086, 2005.
17. Gregg CM, Sladek CD. A compartmentalized, organ-cultured hypothalamo- neurohypophysial system for the study of vasopressin release. Neuroendocrinology 38: 397-402, 1984.
18. Gross G, Hanft G, Rugevics C. 5-Methyl-urapidil discriminates between subtypes of the alpha 1-adrenoceptor. Eur J Pharmacol 151: 333-335, 1988.
19. Hague C, Chen Z, Uberti M, Minneman KP. Alpha(1)-adrenergic receptor subtypes: non-identical triplets with different dancing partners? Life Sci 74: 411-418, 2003.
20. Hiruma H, Bourque CW. P2 purinoceptor-mediated depolarization of rat supraoptic neurosecretory cells in vitro. J Physiol 489: 805-811, 1995.
21. Hussain MB, Marshall I. Alpha(1)-adrenoceptor subtypes mediating contractions of the rat mesenteric artery. Eur J Pharmacol 395: 69-76, 2000.
22. Kaiser RA, Oxhorn BC, Andrews G, Buxton IL. Functional compartmentation of endothelial P2Y receptor signaling. Circ Res 91: 292-299, 2002.
23. Kapoor JR, Sladek CD. Purinergic and adrenergic agonists synergize in stimulating vasopressin and oxytocin release. J Neurosci 20: 8868-8875, 2000.
24. + channel subunit Kv4.2 in hippocampal neurons. Neuron 54: 933-947, 2007.
25. McNeill TH, Sladek JR Jr. Simultaneous monoamine histofluorescence and neuropeptide immunocytochemistry. II. Correlative distribution of catecholamine varicosities and magnocellular neurosecretory neurons in rat supraoptic and paraventricular nuclei. J Comp Neurol 193: 1023-1033, 1980.
26. Melchiorre C, Brasili L, Giardina D, Pigini M, Strappaghetti G. 2-[[[2-(2,6-Dimethoxyphenoxy)ethyl]amino]-methyl]-1,4-benzoxathian: a new antagonist with high potency and selectivity toward alpha 1-adreno-receptors. J Med Chem 27: 1535-1536, 1984. (Pubitemid 15177888)
27. Minneman KP, Theroux TL, Hollinger S, Han C, Esbenshade TA. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Mol Pharmacol 46: 929-936, 1994.
28. Morales D, Madigan J, Cullinane S, Chen J, Heath M, Oz M, Oliver JA, Landry DW. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 100: 226-229, 1999.
29. Morrow AL, Creese I. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Mol Pharmacol 29: 321-330, 1986.
30. Oliver JA, Landry DW. Endogenous and exogenous vasopressin in shock. Curr Opin Crit Care 13: 376-382, 2007.
31. Piascik MT, Guarino RD, Smith MS, Soltis EE, Saussy DL Jr, Perez DM. The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. J Pharmacol Exp Ther 275: 1583-1589, 1995.
32. Randle JCR, Borque CW, Renaud LP. Alpha 1-adrenergic receptor activation depolarizes rat supraoptic neurosecretory neurons in vitro. Am J Physiol Regul Integr Comp Physiol 251: R569-R574, 1986.
33. 1D adrenergic receptor messenger RNA in oxytocin- and corticotropin-releasing hormone-synthesizing neurons in the rat paraventricular nucleus. Neuroscience 91: 639-649, 1999.
34. Sawchenko PE, Swanson LW. The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat. J Comp Neurol 218: 121-144, 1983.
35. Schrader LA, Birnbaum SG, Nadin BM, Ren Y, Bui D, Anderson AE, Sweatt JD. ERK/MAPK regulates the Kv4.2 potassium channel by direct phosphorylation of the pore-forming subunit. Am J Physiol Cell Physiol 290: C852-C861, 2006.
36. Schrader LA, Ren Y, Cheng F, Bui D, Sweatt JD, Anderson AE. Kv4.2 is a locus for PKC and ERK/MAPK cross-talk. Biochem J 417: 705-715, 2009.
37. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med 31: 1752-1758, 2003.
38. Sladek CD, Yagil C. Diverse effects of norepinephrine on vasopressin release may reflect modulation by hypotonicity. J Neuroendocrinol 2: 363-367, 1990.
39. Sladek JR Jr, McNeill TH. Simultaneous monoamine histofluorescence and neuropeptide immunocytochemistry. IV. Verification of catecholamine- neurophysin interactions through single-section analysis. Cell Tissue Res 210: 181-189, 1980.
40. Smith DW, Sibbald JR, Khanna L, Day TA. Rat vasopressin cell responses to simulated hemorrhage: stimulus-dependent role for A1 noradrenergic neurons. Am J Physiol Regul Integr Comp Physiol 268: R1336-R1342, 1995.
41. Song Z, Gomes DA, Stevens W. Role of purinergic P2Y1 receptors in regulation of vasopressin and oxytocin secretion. Am J Physiol Regul Integr Comp Physiol 297: R478-R484, 2009.
42. Song Z, Vijayaraghavan S, Sladek CD. Simultaneous exposure to ATP and phenylephrine induces a sustained elevation in the intracellular calcium concentration in supraoptic neurons. Am J Physiol Regul Integr Comp Physiol 291: R37-R45, 2006.
43. Yagil C, Sladek CD. Osmotic regulation of vasopressin and oxytocin release is rate sensitive in hypothalamoneurohypophysial explants. Am J Physiol Regul Integr Comp Physiol 258: R492-R500, 1990.
44. + current IA in pyramidal neurons in (rat) primary visual cortex. J Neurosci 25: 9185-9194, 2005.